Vault-13

KCK LTD.

HAMILTON, D0 · CIK 1657662 · 13F filing filed 2022-08-10

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$71.2m reported value -30.6% vs Q1 2022
4positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SIGHT SCIENCES INC COM SGHT SGHT 4,776,232 $42.9m60.33% 60.33% UnchangedShares held: Q3 2021 —, Q4 2021 4.8m, Q1 2022 4.8m, Q2 2022 4.8m
2 NEUROPACE INC COM NPCE NPCE 5,621,111 $27.8m39.09% 39.09% UnchangedShares held: Q3 2021 —, Q4 2021 5.6m, Q1 2022 5.6m, Q2 2022 5.6m
3 IMMUNIC INC COM COM 69,704 $242.0k0.34% 0.34% UnchangedShares held: Q3 2021 —, Q4 2021 69.7k, Q1 2022 69.7k, Q2 2022 69.7k
4 AILERON THERAPEUTICS INC COM ALRN ALRN 646,817 $168.0k0.24% 0.24% UnchangedShares held: Q3 2021 —, Q4 2021 646.8k, Q1 2022 646.8k, Q2 2022 646.8k